Gufic Biosciences Limited has informed the Exchange about initial subscription to ordinary shares in Gufic Ireland Limited, Wholly Owned Subsidiary of the Company in Ireland
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has subscribed to 1,000 ordinary shares of Euro 1 each (total Euro 1,000) in its wholly owned subsidiary Gufic Ireland Limited. The Ireland-based subsidiary was incorporated on March 2, 2023, and is yet to start business operations. It will be used for marketing, distribution, purchase and sale of pharmaceutical products. No governmental approvals were needed, and the subscription was entirely in cash with the company holding 100% of the shareholding.
This is a nominal capital infusion into a newly formed wholly owned subsidiary and is unlikely to have any material impact on the stock price or shareholder value. It signals the company's intent to set up an international marketing and distribution presence in Ireland, but actual operations are yet to begin.